hrv trial, page-3

This is whats crazy

Other than a successful licencing deal or final stage 3 trails of a product, this sort of news is as good as it gets for a junior biotech.

Its just awesome news becuase it means that the US FDA have looked at the product and deemed it to be worthwhile to start clinical real life trails.

This in itelf is huge.

BTA 798 a cure for the common cold. A multi billion dollar industry.

Whats a joke is that we may go down today or up in a trickle.

We would have 20% minimum gain if this market understood BTA or biotechs.